Newswire iconNewswireSep 25, 2026

Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants

Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces.

Share this story

Send the public story page.

Useful takeaways from this story.

Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased...

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces.

Details worth keeping

Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app